In this study, we proposed that the application of rNEP or the inhibition of ECE1 could be a good option as a therapeutic tool to mitigate tumor aggressiveness by degrading ET1 or inhibiting its production, respectively (Fig. 7). The gene discussed is EDN1; the disease is neoplasm.